Neue Suche | Kongressdetail
Druckansicht
 
 

3rd Treg Directed Therapies Summit

Evvnt Promotion / evvnt
-
18.05.2021 - 20.05.2021  Online
Time: 09:00 - 17:30
 
Kongressthemen
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.

Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/710471-1?pid=4832
Herr Treg Directed Therapies Summit Team
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developers (Earlybird rates and workshops available): USD 2099.0, Academic (Earlybird rates and workshops available): USD 1899.0, Service Providers (Earlybird rates and workshops available): USD 2599.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

newTreeCharité International AcademyOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellenceEuropean Public Health Association (EUPHA)Ärztekammer für WienAlumni Club Medizinische Universität WienHelix - Forschung & Beratung Wien